Tenderwize
Back to tender search

Open House Original Rebate Contracts 2026-05 Alectinib

Techniker Krankenkasse·Hamburg, Germany·Deadline Jul 30, 2028 · 712 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Originale-Rabattverträge 2026-05 Alectinib

60/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

60 / 100

Complexity

30 / 100

Risk factors

The procedure is explicitly not a public procurement under EU directives; legal recourse is via social courts, not proc...

No estimated contract value or framework maximum is provided. Without this, it is impossible to assess the financial at...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Conclusion of pharmaceutical rebate contracts (Rabattverträge) for the active substance Alectinib
  • Non-exclusive, open to all eligible pharmaceutical entrepreneurs
Show full summary

This is an Open-House procedure (not a traditional public procurement) by Techniker Krankenkasse and other German health insurers for rebate contracts (Rabattverträge) under § 130c SGB V for the active substance Alectinib. Any eligible pharmaceutical entrepreneur can join at any time during the contract period (max 24 months starting 01.08.2026, ending 31.07.2028). No estimated value is provided. The procedure is non-exclusive with uniform conditions. Submission is via email or postal mail at any time. The tender documents are available online but were not analyzed. Notably, the procedure is not subject to standard procurement law; disputes go to social courts.

Risks

The procedure is explicitly not a public procurement under EU directives; legal recourse is via social courts, not proc...

No estimated contract value or framework maximum is provided. Without this, it is impossible to assess the financial at...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as defined in §4 Abs.18 AMG
  • Must hold a valid marketing authorization for the medicinal product containing Alectinib
  • Must have seat in Germany, EU, or EEA

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Original Rebate Contracts 2026-05 Alectinib

Conclusion of pharmaceutical rebate contracts for the active substance Alectinib under an Open-House procedure. The contract duration is up to 24 months, starting 01.08.2026, with automatic termination upon patent expiry. Participation is possible throughout the contract period.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jul 2026 - Jul 2028

Category

Pharmaceutical products

Deadline

Deadline Jul 30, 2028

Procurement Details

Publication date
01 Jul 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
455118-2026

Documents (1)

Similar tenders